MA
AUXL

MUFG Americas’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

MUFG Americas’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-17,300
Closed -$288K – 1662
2013
Q2 		$288K Buy
+17,300
New +$276K 0.01% 797

Other funds holding AUXL

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MUFG Americas's AUXL Position: Q3 2013 in Review

MUFG Americas sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2013, closing a stake of 17,300 shares — an estimated $288K sold.

MUFG Americas first reported a position in AUXL in Q2 2013 and held it in 1 quarter. The position peaked at $288K in Q2 2013. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2013.

  • MUFG Americas reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • MUFG Americas sold 17,300 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2013, an estimated $288K.
  • MUFG Americas first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • MUFG Americas's AUXILIUM PHARAMCEUTICALS INC position peaked at $288K in Q2 2013.
  • 150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2013.

Based on MUFG Americas's 13F filing for Q3 2013, filed 8 Nov 2013.